Article
Broadening our understanding of genetic risk for scleroderma/systemic sclerosis by querying the chromatin architecture surrounding the risk haplotypes.
BMC medical genomics - 24 Apr 2021
Poppenberg Kerry E, Tutino Vincent M, Tarbell Evan, Jarvis James N
Abstract excerpt
BACKGROUND: Genetic variants in the human leukocyte antigen (HLA) locus contribute to the risk for developing scleroderma/systemic sclerosis (SSc). However, there are other replicated loci that also contribute to genetic risk for SSc, and it is unknown whether genetic risk in these non-HLA loci acts primarily on the vasculature, immune system, fibroblasts, or other relevant cell types. We used the Cistrome...
Topics
Join the communities discussing this publication.
